
A zzso randomized, controlled trial was conducted comparing active treatment with zzso in 227 patients with breast, zzso lung and other solid forms of zzso Combination therapy, zzso conventionally employed for the various types of tumor involved, was associated with zzso zzso zzso or zzso (110 zzso zzso was given orally as zzso as a dose of 500 zzso zzso for 6 zzso The results were, briefly, as zzso The zzso of zzso was significantly lower in the groups receiving zzso in patients with breast and zzso cancer zzso less than zzso zzso of the lung and other solid forms showed no such zzso The zzso of zzso was the same in all disease zzso zzso responses zzso + zzso were observed in zzso zzso of breast cancer patients treated with CT + zzso and in zzso zzso of those given CT + zzso The difference was significant zzso less than zzso zzso parameters also showed more improvement in the zzso group than in the patients given CT zzso No significant differences were found for the other types of zzso but the numbers in this population were very zzso In a group of 45 patients, zzso III a zzso zzso III zzso zzso zzso zzso zzso zzso zzso zzso factor VIII C zzso factor VIII zzso zzso zzso and factor IX C zzso were zzso The most interesting zzso findings were an increase in zzso III zzso and zzso zzso and in zzso This suggests that zzso does not increase the risk of zzso and might even, to some extent, impede zzso zzso zzso AT 250 zzso 

